Surfactant is a lipoprotein complex secreted by type II alveolar cells and Clara cells that lines the alveoli. It is composed mainly of phospholipids like DPPC, proteins, and ions. The surfactant proteins SP-B and SP-C along with phospholipids form a film that reduces surface tension preventing alveolar collapse during exhalation. Surfactant deficiency can cause respiratory distress syndrome in infants and adults by making it difficult to inflate the lungs.
Surfactant & compliance, LAW OF LAPLACE, Work of Breathing (the guyton and ha...Maryam Fida
It is a lipoprotein mixture present in thin layer of fluid lining the alveoli at the air fluid interface.
COMPOSITION
It is composed of
Apoprotein
Calcium ions
Phospholipids i.e. dipalmitoyl lecithin
Surfactant is secreted by
1. Mainly type II alveolar cells in the lungs.
2. Clara cells, which are situated in the bronchioles.
It lowers the surface tension of fluid lining the alveoli.
Surface tension is inversely proportional to surfactant concentration.
During inspiration surfactant molecules move apart as lungs are expanded and during expiration surfactant molecules become concentrated as lungs shorten.
When there is no surfactant, Surface Tension is 50 dynes/cm. when surfactant is present it is 5-30 dynes/cm depending upon the concentration
Prevents collapse of lungs
Stabilize size of alveoli
Surfactant helps to keep lungs expanded. If there is deficiency of surfactant then the pressure of -20 to -30 mm of Hg will be required to keep the lungs expanded
Surfactant also helps to keep the alveoli dry and prevent development of pulmonary edema.
Surfactant is also helpful in lung expansion at birth. If there is deficiency then there is Respiratory Distress Syndrome.
LAW OF LAPLACE:
pressure required to keep a hollow viscous distended = 2 T/R
Where T is tension and R is radius.
During expiration, size of alveoli decreases so R is decreased and if T does not decrease, much higher pressure will be required to keep the alveoli distended.
When adequate amount of surfactant is there T also decreases so increased pressure is not required. This prevents the collapse of lungs and also stabilizes the equal size of alveoli
Definition:
“Compliance is the measure of expansibility or distensibility of the lungs. It indicates with how much ease lungs can be expanded”.
Work of Breathing
In certain diseases there is increased work of breathing and depending upon the nature of breath there will be specific increase in work of breathing.
In asthma there is increase in work of breathing to overcome airway resistance
In restrictive lung diseases there is increase work of breathing in both tissue resistance and elastic recoil.
The apparatus used to measure
Volume of air exchanged during breathing
Respiratory rate
The record is called a spirogram
Upward deflection inhalation
Downward deflection exhalation
Surfactant & compliance, LAW OF LAPLACE, Work of Breathing (the guyton and ha...Maryam Fida
It is a lipoprotein mixture present in thin layer of fluid lining the alveoli at the air fluid interface.
COMPOSITION
It is composed of
Apoprotein
Calcium ions
Phospholipids i.e. dipalmitoyl lecithin
Surfactant is secreted by
1. Mainly type II alveolar cells in the lungs.
2. Clara cells, which are situated in the bronchioles.
It lowers the surface tension of fluid lining the alveoli.
Surface tension is inversely proportional to surfactant concentration.
During inspiration surfactant molecules move apart as lungs are expanded and during expiration surfactant molecules become concentrated as lungs shorten.
When there is no surfactant, Surface Tension is 50 dynes/cm. when surfactant is present it is 5-30 dynes/cm depending upon the concentration
Prevents collapse of lungs
Stabilize size of alveoli
Surfactant helps to keep lungs expanded. If there is deficiency of surfactant then the pressure of -20 to -30 mm of Hg will be required to keep the lungs expanded
Surfactant also helps to keep the alveoli dry and prevent development of pulmonary edema.
Surfactant is also helpful in lung expansion at birth. If there is deficiency then there is Respiratory Distress Syndrome.
LAW OF LAPLACE:
pressure required to keep a hollow viscous distended = 2 T/R
Where T is tension and R is radius.
During expiration, size of alveoli decreases so R is decreased and if T does not decrease, much higher pressure will be required to keep the alveoli distended.
When adequate amount of surfactant is there T also decreases so increased pressure is not required. This prevents the collapse of lungs and also stabilizes the equal size of alveoli
Definition:
“Compliance is the measure of expansibility or distensibility of the lungs. It indicates with how much ease lungs can be expanded”.
Work of Breathing
In certain diseases there is increased work of breathing and depending upon the nature of breath there will be specific increase in work of breathing.
In asthma there is increase in work of breathing to overcome airway resistance
In restrictive lung diseases there is increase work of breathing in both tissue resistance and elastic recoil.
The apparatus used to measure
Volume of air exchanged during breathing
Respiratory rate
The record is called a spirogram
Upward deflection inhalation
Downward deflection exhalation
Random motion of molecules
Movement in both directions through the membranes & fluids of the respiratory structure
Mechanism & rate of molecule transfer dependant on physics of gas diffusion and partial pressures of gases involved
Random motion of molecules
Movement in both directions through the membranes & fluids of the respiratory structure
Mechanism & rate of molecule transfer dependant on physics of gas diffusion and partial pressures of gases involved
The slides below are about a cell membrane. They define a cell membrane and also discuss how molecules moves in and out of the cell membrane using different channels.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
2. •Surfactant is a surface acting material or agent that is
responsible for lowering the surface tension of a fluid.
•Surfactant that lines the epithelium of the alveoli in lungs
is known as pulmonary surfactant and it decreases the
surface tension on the alveolar membrane.
•Source of secretion of pulmonary surfactant
Pulmonary surfactant is secreted by two types of cells:
1. Type II alveolar epithelial cells in the lungs, which are called
surfactant secreting alveolar cells or pneumocytes.
• Characteristic feature of these cells is the presence of microvilli
on their alveolar surface.
2. Clara cells, which are situated in the bronchioles.
These cells are also called bronchiolar exocrine cells.
SURFACTANT
3.
4. Chemistry of surfactant
Surfactant is a lipoprotein complex formed by lipids especially
phospholipids, proteins and ions.
1. Phospholipids: Phospholipids form about 75% of the
surfactant. Major phospholipid present in the surfactant is
dipalmitoylphosphatidylcholine (DPPC).
2. Other lipids: Other lipid substances of surfactant are
triglycerides and phosphatidylglycerol (PG).
5. 3. Proteins: Proteins of the surfactant are called specific
surfactant proteins.
There are four main surfactant proteins, called SPA, SPB, SPC
and SPD.
•SPA and SPD are hydrophilic, while SPB and SPC are
hydrophobic.
SP-A, SP-D is a glycoprotein. Both SP-A and SP-D are
members of the collectin family are involved in innate
immunity in the conducting airway as well as in the alveoli.
•SP-A is a large glycoprotein and has a collagen-like domain
within its structure. It has multiple functions, including
regulation
of the feedback uptake of surfactant by the type II alveolar
epithelial cells that secrete it
6. 4. Ions: Ions present in the surfactant are mostly calcium
ions.
•SP-B and SP-C are smaller proteins,which are the of the
key protein members of the monomolecular film of
surfactant.
• SURFACTANT becomes inactive in the absence of
proteins.
7. Formation of surfactant requires many
substances.
Formation of tubular myelin requires DPPC, PG and the
hydrophobic proteins, SPB and SPC. Formation of
surfactant film requires SPB, SPC and PG.
• Type II alveolar epithelial cells occupy only about 5% of
alveolar surface.
• It is facilitated by PG and calcium ions.
Glucocorticoids play important role in the formation
of surfactant.
8. Formation of surfactant
•Type II alveolar epithelial cells and Clara cells have a special
type of membrane bound organelles called lamellar bodies,
which form the intracellular source of surfactant.
•Laminar bodies contain surfactant phospholipids and
surfactant proteins.
•These materials are synthesized in endoplasmic reticulum
and stored in laminar bodies.
•By means of exocytosis, lipids and proteins of lamellar bodies
are released into surface fluid lining the alveoli.
• Here, in the presence of surfactant proteins and calcium, the
phospholipids are arranged into a lattice (meshwork)
structure called tubular myelin.
9. •Tubular myelin is in turn converted into surfactant in the
form of a film that spreads over the entire surface of
alveoli.
Most of the surfactant is absorbed into the type II
alveolar cells, catabolized and the products are loaded
into lamellar bodies for recycling.
10.
11. Functions of surfactant
1. Surfactant reduces the surface tension in the alveoli of
lungs and prevents collapsing tendency of lungs.
12. 2. Surfactant is responsible for stabilization of the alveoli,
which is necessary to withstand the collapsing tendency.
3. It plays an important role in the inflation of lungs after
birth.
•In fetus, the secretion of surfactant begins after the 3rd
month,the lungs are solid and not expanded.
Soon after birth, the first breath starts because of the
stimulation of respiratory centers by hypoxia and
hypercapnea.
Although the respiratory movements are attempted by the
infant, the lungs tend to collapse repeatedly and the
presence of surfactant in the alveoli prevents the lungs
from collapsing.
13. 4. Another important function of surfactant is its role
in defense within the lungs against infection and
inflammation.
• Hydrophilic proteins SPA and SPD destroy the
bacteria and viruses by means of opsonization.
14. Surfactant acts by the following mechanism:
Phospholipid molecule in the surfactant has two
portions. One portion of the molecule is hydrophilic.
This Portion Dissolves In water and lines The alveoli.
Other portion is Hydrophobic and it is Directed towards
the alveolar air.
This surface of the Phospholipid Along with other portion
spreads over the
alveoli and reduces the surface tension.
SPB and SPC play active role in this process.
15.
16. It has been calculated that if it were not present,
the unopposed surface tension in the alveoli would
produce a 20mmHg force favouring transudation of
fluid from the blood into the alveoli.
the deficiency of surfactant increases
the susceptibility for bacterial and viral infections.
17. Effect of deficiency of surfactant –
Respiratory Distress Syndrome -
Absence of surfactant in infants, causes collapse of lungs
and the condition is called respiratory distress syndrome
or hyaline membrane disease. Deficiency of surfactant
occurs in adults also and it is called
Adult respiratory distress syndrome (ARDS).
CLINICAL